Stockscreener 앱 받기
50.31
1.99%
-1.02
전일 마감가:
$51.33
열려 있는:
$51.35
하루 거래량:
463.23K
Relative Volume:
0.94
시가총액:
$1.44B
수익:
$86.93M
순이익/손실:
$-1.48M
주가수익비율:
-709.59
EPS:
-0.0709
순현금흐름:
$431.00K
1주 성능:
-8.88%
1개월 성능:
-10.72%
6개월 성능:
+105.94%
1년 성능:
+174.32%
1일 변동 폭
$49.07
$51.87
1주일 범위
$49.07
$57.00
52주 변동 폭
$14.27
$66.37
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
명칭
Eton Pharmaceuticals Inc
전화
(847) 787-7361
주소
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
50.31 | 1.44B | 86.93M | -1.48M | 431.00K | -0.0709 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-07-17 | 개시 | Canaccord Genuity | Buy |
| 2025-01-23 | 재확인 | H.C. Wainwright | Buy |
| 2025-01-10 | 개시 | B. Riley Securities | Buy |
| 2025-01-06 | 재확인 | H.C. Wainwright | Buy |
| 2024-09-04 | 재개 | H.C. Wainwright | Buy |
| 2024-05-06 | 개시 | Craig Hallum | Buy |
| 2021-10-14 | 재개 | B. Riley Securities | Buy |
| 2021-01-04 | 재확인 | H.C. Wainwright | Buy |
| 2019-09-20 | 개시 | B. Riley FBR | Buy |
| 2019-06-10 | 개시 | H.C. Wainwright | Buy |
모두보기
Eton Pharmaceuticals Inc 주식(ETON)의 최신 뉴스
Form 4 Eton Pharmaceuticals Inc For: 11 October By Investing.com - Investing.com Nigeria
Form 4 Eton Pharmaceuticals Inc For: 11 October By Investing.com - Investing.com South Africa
Eton Pharmaceuticals CBO David Krempa sells $229k in stock By Investing.com - Investing.com South Africa
Eton Pharmaceuticals CBO David Krempa sells $229k in stock - Investing.com
Form 4 Eton Pharmaceuticals Inc For: 11 October By Investing.com - Investing.com Australia
Form 4 Eton Pharmaceuticals Inc For: 11 October By Investing.com - Investing.com UK
ETON Stock Surges 108% in Six Months: Here's What You Need to Know - Zacks Investment Research
To cover stock-grant vesting, Eton Pharmaceuticals (ETON) officer proposes selling 4,166 shares. - Stock Titan
ETON Stock Rises as Eton Pharmaceuticals Secures Impavido Rights - timothysykes.com
Eton Pharmaceuticals (ETON) Slides 9.55% to $53.54 as Shares Retreat Toward SupportValue Factor - dars.gov.et
Bank of America Corp DE Acquires New Shares in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Form 8K Eton Pharmaceuticals Inc For: 28 September By Investing.com - Investing.com Nigeria
Form 8K Eton Pharmaceuticals Inc For: 28 September By Investing.com - Investing.com Canada
Neurogene Inc. (NGNE) Stock Price & News - Syfe
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Up 5.9%Should You Buy? - MarketBeat
Eton Pharmaceuticals (NasdaqGM:ETON) Stock Forecast & Analyst Predictions - Simply Wall Street
Eton Pharmaceutcials (ETON) Stock Price, News & Analysis - Stock Titan
Eton Pharmaceuticals stock holds steady as insider sales and recent results shape the picture - AD HOC NEWS
Eton Pharmaceuticals stock holds steady as investors eye latest results - AD HOC NEWS
HighTower Advisors LLC Acquires 34,484 Shares of Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Hsbc Holdings PLC Makes New $1.53 Million Investment in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Nuvectis Pharma, Inc. (NVCT) Stock Price & News - Syfe
Eton Pharmaceuticals (ETON) Heads To Wells Fargo Conference As Fair Value Debate Stays Open - simplywall.st
118,249 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Bank of New York Mellon Corp - MarketBeat
(ETON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
ETON stock holds firm after latest quarter shows steady growth - AD HOC NEWS
Sigma Planning Corp Takes Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
PAUL MAIER V At Eton Pharmaceuticals Executes Options Exercise, Realizing $2.84M - Benzinga
Hsbc Holdings PLC Invests $1.53 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals Director Paul V. Maier Executes Stock Options and Sells Shares on August 28, 2026 - Kalkine Media
Eton Pharmaceuticals (ETON) director unloads 50K shares after option exercise - Stock Titan
34,027 Shares in Eton Pharmaceuticals, Inc. $ETON Acquired by Jefferies Financial Group Inc. - MarketBeat
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Deutsche Bank AG Purchases Shares of 26,522 Eton Pharmaceuticals, Inc. $ETON - MarketBeat
BlackRock Inc. Invests $68.63 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (ETON) Slips 1.74% as Shares Pull Back Toward Key SupportPrice Action Signals - dars.gov.et
Navellier & Associates Inc. Makes New Investment in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals, Inc. $ETON Stock Holdings Increased by Bank of America Corp DE - MarketBeat
1,175,951 Shares in Eton Pharmaceuticals, Inc. $ETON Purchased by Nantahala Capital Management LLC - MarketBeat
Cannell Capital LLC Acquires New Stake in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals (NASDAQ:ETON) Director Sells $2,953,500.00 in Stock - MarketBeat
Eton Pharmaceuticals (NASDAQ: ETON) insider sells 50K shares - Stock Titan
Bank of Nova Scotia Acquires New Position in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Eton Pharmaceuticals Insider Sold Shares Worth $2,953,572, According to a Recent SEC Filing - Yahoo Finance
Eton Pharmaceuticals (NASDAQ:ETON) Shares Down 4.4%Here's Why - MarketBeat
Eton leaders will hold one-on-one meetings at Wells Fargo’s Boston event - stocktitan.net
Pillsbury Lake Capital LLC Invests $14.02 Million in Eton Pharmaceuticals, Inc. $ETON - MarketBeat
Jim Cramer: 'You Could Make Some Money With This 5.6% Yield' - sahmcapital.com
Eton's Galzin TM And False Ad Suit Survives Dismissal Bid - Law360
Eton Pharmaceuticals Can Proceed With ‘Gluzin’ Supplement Suit - Bloomberg Law News
Eton Pharmaceuticals Inc (ETON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Eton Pharmaceuticals Inc 주식 (ETON) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Krempa David | Officer |
Oct 06 '26 |
Proposed Sale |
55.07 |
4,166 |
229,406 |
0 |
| MAIER PAUL V | Director |
Aug 28 '26 |
Option Exercise |
3.78 |
50,000 |
189,000 |
109,745 |
| MAIER PAUL V | Director |
Aug 28 '26 |
Sale |
59.07 |
50,000 |
2,953,572 |
59,745 |
| MAIER PAUL V | Director |
Aug 28 '26 |
Proposed Sale |
59.07 |
50,000 |
2,953,530 |
0 |
| Krempa David | Officer |
Aug 24 '26 |
Proposed Sale |
65.07 |
25,000 |
1,626,750 |
0 |
| Krempa David | Chief Business Officer |
Aug 24 '26 |
Sale |
65.07 |
25,000 |
1,626,750 |
37,025 |
| Krempa David | Chief Business Officer |
Aug 24 '26 |
Option Exercise |
7.31 |
25,000 |
182,750 |
62,025 |
| BRYNJELSEN SEAN | President & CEO |
Aug 20 '26 |
Sale |
60.70 |
91,022 |
5,525,301 |
961,194 |
| BRYNJELSEN SEAN | Director |
Aug 19 '26 |
Proposed Sale |
63.43 |
100,000 |
6,343,000 |
0 |
| BRYNJELSEN SEAN | President & CEO |
Aug 19 '26 |
Sale |
62.65 |
8,978 |
562,472 |
1,052,216 |
0.03%
2.08%
자본화:
|
볼륨(24시간):